Global Large Volume Wearable Injectors Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Large Volume Wearable Injectors Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Large Volume Wearable Injectors, also known as bolus injectors or non-insulin patch pumps, are drug delivery devices that have above 1 ml capacity of injectable volume. These devices can offer a range of benefits to patients, for example, to make administration more convenient and reduce patient suffering.
Large Volume Wearable Injectors report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Large Volume Wearable Injectors market is projected to reach US$ 11290 million in 2034, increasing from US$ 1471 million in 2022, with the CAGR of 33.4% during the period of 2024 to 2034. Demand from Cancer Treatment and Auto-immune Treatment are the major drivers for the industry.
The major players in global Large Volume Wearable Injectors market include Unilife Corporation, BD Medical, etc. The top 2 players occupy about 45% shares of the global market. North America is the main market, and occupies about 70% of the global market. Electronical Injectors is the main type, with a share about 70%. Auto-immune Treatment is the main application, which holds a share about 40%.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Large Volume Wearable Injectors market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
West Pharmaceuticals
Unilife Corporation
CeQur
Sensile Medical AG
BD Medical
Enable Injections
Roche Laboratories
scPharmaceuticals
SteadyMed Therapeutics
Johnson & Johnson
Segment by Type
Electronical Injectors
Mechanical Injectors
Others
Cancer Treatment
Auto-immune Treatment
Blood Disorders Treatment
Others
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Large Volume Wearable Injectors market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Large Volume Wearable Injectors, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Large Volume Wearable Injectors industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Large Volume Wearable Injectors in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Large Volume Wearable Injectors introduction, etc. Large Volume Wearable Injectors Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Large Volume Wearable Injectors market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
Large Volume Wearable Injectors report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Large Volume Wearable Injectors market is projected to reach US$ 11290 million in 2034, increasing from US$ 1471 million in 2022, with the CAGR of 33.4% during the period of 2024 to 2034. Demand from Cancer Treatment and Auto-immune Treatment are the major drivers for the industry.
The major players in global Large Volume Wearable Injectors market include Unilife Corporation, BD Medical, etc. The top 2 players occupy about 45% shares of the global market. North America is the main market, and occupies about 70% of the global market. Electronical Injectors is the main type, with a share about 70%. Auto-immune Treatment is the main application, which holds a share about 40%.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Large Volume Wearable Injectors market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
West Pharmaceuticals
Unilife Corporation
CeQur
Sensile Medical AG
BD Medical
Enable Injections
Roche Laboratories
scPharmaceuticals
SteadyMed Therapeutics
Johnson & Johnson
Segment by Type
Electronical Injectors
Mechanical Injectors
Others
Segment by Application
Cancer Treatment
Auto-immune Treatment
Blood Disorders Treatment
Others
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Large Volume Wearable Injectors market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Large Volume Wearable Injectors, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Large Volume Wearable Injectors industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Large Volume Wearable Injectors in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Large Volume Wearable Injectors introduction, etc. Large Volume Wearable Injectors Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Large Volume Wearable Injectors market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.